噻托溴铵奥达特罗能倍乐医保可以报吗

The main ingredient is tiotropium bromide, which is a specific anticholinergic drug that can produce bronchodilation and therefore can be used for the treatment of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Tiotropium bromide, olodaterol, and Respimat produce a dilation effect on bronchial smooth muscle by binding to the M3 receptor on smooth muscle. This effect is competitive and reversible. In vivo and in vitro studies have shown that tiotropium bromide, olodaterol and repimat can inhibit methacholine-induced bronchoconstriction in a dose-dependent and sustainable 24 hours. Tiotropium bromide, olodaterol, and Respimat have outstanding localization selectivity in bronchial dilation.

The approval of tiotropium, olodaterol, and repimat was based on data from two pivotal Phase III trials (TONADO-1, -2). The study involved more than 5,000 COPD patients. Data showed that compared with placebo, tiotropium bromide, and olodaterol monotherapy, Respimat produced a statistically significant improvement in patients' lung function (FEV1) and had a similar safety profile to tiotropium bromide or olodaterol.

Can tiotropium bromide, olodaterol, and Respimat be covered by medical insurance?

It is understood that tiotropium bromide, olodaterol, and repimat are already on the market in China, so patients can purchase the drug at major domestic regular pharmacies or hospital pharmacies with a prescription issued by a doctor. Tiotropium bromide, olodaterol and Respimat have been included in Category B of medical insurance, but the reimbursement standards of medical insurance vary from place to place. Patients can go to local hospitals for consultation.

It is effective for 24 hours, so it only needs to be used once a day. In order to ensure the therapeutic effect, it is best for patients to use it at the same time every day, spray it twice every time, and do not overdose. Tiotropium, Odaterol, and Respimat are prescription drugs and you must consult your doctor before starting treatment. It should not be used if the patient is allergic to the drug or its ingredients.

Recommended related hot articles: /newsDetail/83749.html